China (Mainland)
Premiumsupplier 
75607-67-9 Fludarabin Phosphate CAS NO.75607-67-9
- FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T
- Available Specifications:
99%(1-100)Kilogram
- Product Details
Keywords
- 75607-67-9
- Fludarabine
- 9-b-D-Arabinofuranosyl-2-fluoroadenine-5-(dihydrogen phosphate)
Quick Details
- ProName: 75607-67-9 Fludarabin Phosphate
- CasNo: 75607-67-9
- Molecular Formula: C10H13FN5O7P
- Appearance: Almost white to white crystalline powd...
- Application: pharmaceutical
- DeliveryTime: one week
- PackAge: 25kg/drum
- Port: Shanghai
- ProductionCapacity: 200 Metric Ton/Year
- Purity: 99%min
- Storage: Protect from humidity; keep in a dry, ...
- Transportation: BY SEA,AIR
- LimitNum: 1 Kilogram
- Related Substances: 0.1%
- Residue on Ignition: 0.2%
- Heavy Metal: 10ppm
- Valid Period: 2years
- CAS: 75607-67-9
Superiority
Fludarabine Phosphate
CAS: 75607-67-9
Appearance:Almost white to white crystalline powder
Assay: 99.0%
Packing: 1kg/aluminum tin; 25kg/carton barrel.
Storage: Protect from humidity; keep in a dry, cool, and shady place.
Remarks: Only for chemical products.
Details
IUPAC Name: [5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Molecular Formula: C10H13FN5O7P
Molecular Weight: 365.21 g/mol
Classification Code: Antimetabolites; Antimetabolites, antineoplastic; Antineoplastic; Antineoplastic Agents; Drug / Therapeutic Agent; Human Data; Immunologic Factors; Immunosuppressive agents; Noxae
Product Categories: Active Pharmaceutical Ingredients; Antineoplastics; Antineoplastic; API
XLogP3: -3.1
H-Bond Donor: 5
H-Bond Acceptor: 12
Surface Tension: 130.7 dyne/cm
Density: 2.39 g/cm3
Flash Point: 476.4 °C
Enthalpy of Vaporization: 131.58 kJ/mol
Boiling Point: 864.2 °C at 760 mmHg
Vapour Pressure of Fludarabine phosphate (CAS NO.75607-67-9): 7.38E-32 mmHg at 25 °C
Uses
Fludarabine phosphate (CAS NO.75607-67-9) is a chemotherapy drug used in the treatment of hematological malignancies. It is highly effective in the treatment of chronic lymphocytic leukemia.